{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:40:47Z","timestamp":1792190447221,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203157"],"award-info":[{"award-number":["82203157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02952-7","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:54:36Z","timestamp":1779328476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BIRC6 prevents GSDME-mediated pyroptosis and promotes cisplatin resistance via a non-canonical UBC domain-dependent steric hindrance"],"prefix":"10.1186","volume":"24","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2952_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2952_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, et al. Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22:249\u201374.","journal-title":"J Natl Compr Canc Netw"},{"key":"2952_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/222385a0","volume":"222","author":"B Rosenberg","year":"1969","unstructured":"Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Platinum compounds: a new class of potent antitumour agents. Nature. 1969;222:385\u20136.","journal-title":"Nature"},{"key":"2952_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573\u201384.","journal-title":"Nat Rev Cancer"},{"key":"2952_CR5","doi-asserted-by":"publisher","first-page":"e10608","DOI":"10.1016\/j.heliyon.2022.e10608","volume":"8","author":"R Ranasinghe","year":"2022","unstructured":"Ranasinghe R, Mathai ML, Zulli A. Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon. 2022;8:e10608.","journal-title":"Heliyon"},{"key":"2952_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3892\/or.2022.8293","volume":"47","author":"L Yang","year":"2022","unstructured":"Yang L, Xie H-J, Li Y-Y, Wang X, Liu X-X, Mai J. Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer (Review). Oncol Rep. 2022;47:82.","journal-title":"Oncol Rep"},{"key":"2952_CR7","doi-asserted-by":"publisher","first-page":"114778","DOI":"10.1016\/j.biopha.2023.114778","volume":"163","author":"H Hu","year":"2023","unstructured":"Hu H, Li B, Wang J, Tan Y, Xu M, Xu W, et al. New advances into cisplatin resistance in head and neck squamous carcinoma: mechanisms and therapeutic aspects. Biomed Pharmacother. 2023;163:114778.","journal-title":"Biomed Pharmacother"},{"key":"2952_CR8","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, et al. NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res. 2023;83:1666\u201383.","journal-title":"Cancer Res"},{"key":"2952_CR9","doi-asserted-by":"publisher","first-page":"e2308762","DOI":"10.1002\/adma.202308762","volume":"36","author":"W Wang","year":"2024","unstructured":"Wang W, Yang F, Zhang L, Wang M, Yin L, Dong X, et al. Targeting DNA damage and repair machinery via delivering WEE1 inhibitor and platinum (IV) prodrugs to stimulate STING pathway for maximizing chemo-immunotherapy in bladder cancer. Adv Mater. 2024;36:e2308762.","journal-title":"Adv Mater"},{"key":"2952_CR10","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.drup.2022.100913","volume":"66","author":"J Wu","year":"2023","unstructured":"Wu J, Zhou Z, Li J, Liu H, Zhang H, Zhang J, et al. CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK\/ERK axis. Drug Resist Updat. 2023;66:100913.","journal-title":"Drug Resist Updat"},{"key":"2952_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-023-02781-3","volume":"42","author":"Z Han","year":"2023","unstructured":"Han Z, Jia Q, Zhang J, Chen M, Wang L, Tong K, et al. Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis. J Exp Clin Cancer Res. 2023;42:228.","journal-title":"J Exp Clin Cancer Res"},{"key":"2952_CR12","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41467-024-47080-3","volume":"15","author":"Y-Y Bi","year":"2024","unstructured":"Bi Y-Y, Chen Q, Yang M-Y, Xing L, Jiang H-L. Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer. Nat Commun. 2024;15:2759.","journal-title":"Nat Commun"},{"key":"2952_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15:174.","journal-title":"J Hematol Oncol"},{"key":"2952_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"key":"2952_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7150\/thno.91814","volume":"14","author":"DKW Ocansey","year":"2024","unstructured":"Ocansey DKW, Qian F, Cai P, Ocansey S, Amoah S, Qian Y, et al. Current evidence and therapeutic implication of panoptosis in cancer. Theranostics. 2024;14:640\u201361.","journal-title":"Theranostics"},{"key":"2952_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42:88\u2013116.","journal-title":"Cancer Commun (Lond)"},{"key":"2952_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535:111\u20136.","journal-title":"Nature"},{"key":"2952_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41580-022-00564-w","volume":"24","author":"P Vandenabeele","year":"2023","unstructured":"Vandenabeele P, Bultynck G, Savvides SN. Pore-forming proteins as drivers of membrane permeabilization in cell death pathways. Nat Rev Mol Cell Biol. 2023;24:312\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2952_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-022-00906-9","volume":"8","author":"F Yao","year":"2022","unstructured":"Yao F, Jin Z, Zheng Z, Lv X, Ren L, Yang J, et al. HDAC11 promotes both NLRP3\/caspase-1\/GSDMD and caspase-3\/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells. Cell Death Discov. 2022;8:112.","journal-title":"Cell Death Discov"},{"key":"2952_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12943-024-02183-9","volume":"23","author":"H Wang","year":"2024","unstructured":"Wang H, Wang T, Yan S, Tang J, Zhang Y, Wang L, et al. Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication. Mol Cancer. 2024;23:268.","journal-title":"Mol Cancer"},{"key":"2952_CR21","doi-asserted-by":"publisher","first-page":"1062225","DOI":"10.3389\/fimmu.2022.1062225","volume":"13","author":"M Khan","year":"2022","unstructured":"Khan M, Ai M, Du K, Song J, Wang B, Lin J, et al. Pyroptosis relates to tumor microenvironment remodeling and prognosis: a pan-cancer perspective. Front Immunol. 2022;13:1062225.","journal-title":"Front Immunol"},{"key":"2952_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103.","journal-title":"Nature"},{"key":"2952_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41419-021-03458-5","volume":"12","author":"X Shen","year":"2021","unstructured":"Shen X, Wang H, Weng C, Jiang H, Chen J. Caspase 3\/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity. Cell Death Dis. 2021;12:186.","journal-title":"Cell Death Dis"},{"issue":"8","key":"2952_CR24","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.cell.2026.03.024","volume":"189","author":"M Conrad","year":"2026","unstructured":"Conrad M, Strasser A, Jost PJ, Yuan J, Shao F, Vandenabeele P, et al. Cell death in cancer. Cell. 2026;189(8):2322\u201356.","journal-title":"Cell"},{"key":"2952_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s10495-019-01515-1","volume":"24","author":"C-C Zhang","year":"2019","unstructured":"Zhang C-C, Li C-G, Wang Y-F, Xu L-H, He X-H, Zeng Q-Z, et al. Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3\/GSDME activation. Apoptosis. 2019;24:312\u201325.","journal-title":"Apoptosis"},{"key":"2952_CR26","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41423-024-01231-0","volume":"21","author":"S Chen","year":"2024","unstructured":"Chen S, Zhang P, Zhu G, Wang B, Cai J, Song L, et al. Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma. Cell Mol Immunol. 2024;21:1505\u201321.","journal-title":"Cell Mol Immunol"},{"key":"2952_CR27","doi-asserted-by":"publisher","first-page":"216206","DOI":"10.1016\/j.canlet.2023.216206","volume":"564","author":"S Li","year":"2023","unstructured":"Li S, Yue M, Xu H, Zhang X, Mao T, Quan M, et al. Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer. Cancer Lett. 2023;564:216206.","journal-title":"Cancer Lett"},{"key":"2952_CR28","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1038\/s41467-024-49675-2","volume":"15","author":"SY Huang","year":"2024","unstructured":"Huang SY, Gong S, Zhao Y, Ye ML, Li JY, He QM, et al. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma. Nat Commun. 2024;15:5300.","journal-title":"Nat Commun"},{"key":"2952_CR29","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1002\/hep.30529","volume":"69","author":"C Ge","year":"2019","unstructured":"Ge C, Vilfranc CL, Che L, Pandita RK, Hambarde S, Andreassen PR, et al. The BRUCE-ATR signaling axis is required for accurate DNA replication and suppression of liver cancer development. Hepatology. 2019;69:2608\u201322.","journal-title":"Hepatology"},{"key":"2952_CR30","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1080\/15548627.2018.1471311","volume":"14","author":"F Ikeda","year":"2018","unstructured":"Ikeda F. The anti-apoptotic ubiquitin conjugating enzyme BIRC6\/BRUCE regulates autophagosome-lysosome fusion. Autophagy. 2018;14:1283\u20134.","journal-title":"Autophagy"},{"key":"2952_CR31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1126\/science.ade8873","volume":"379","author":"JF Ehrmann","year":"2023","unstructured":"Ehrmann JF, Grabarczyk DB, Heinke M, Deszcz L, Kurzbauer R, Hudecz O, et al. Structural basis for regulation of apoptosis and autophagy by the BIRC6\/SMAC complex. Science. 2023;379:1117\u201323.","journal-title":"Science"},{"key":"2952_CR32","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1126\/science.ade5750","volume":"379","author":"M Hunkeler","year":"2023","unstructured":"Hunkeler M, Jin CY, Fischer ES. Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases. Science. 2023;379:1105\u201311.","journal-title":"Science"},{"key":"2952_CR33","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1126\/science.ade8840","volume":"379","author":"L Dietz","year":"2023","unstructured":"Dietz L, Ellison CJ, Riechmann C, Cassidy CK, Felfoldi FD, Pinto-Fern\u00e1ndez A, et al. Structural basis for SMAC-mediated antagonism of caspase inhibition by the giant ubiquitin ligase BIRC6. Science. 2023;379:1112\u20137.","journal-title":"Science"},{"key":"2952_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/1078-0432.CCR-16-0718","volume":"23","author":"ISU Luk","year":"2017","unstructured":"Luk ISU, Shrestha R, Xue H, Wang Y, Zhang F, Lin D, et al. BIRC6 targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer. Clin Cancer Res. 2017;23:1542\u201351.","journal-title":"Clin Cancer Res"},{"key":"2952_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.lungcan.2020.04.030","volume":"145","author":"J-M Zhong","year":"2020","unstructured":"Zhong J-M, Zhang G-F, Lin L, Li D-Y, Liu Z-H. A novel EML4-ALK BIRC6-ALK double fusion variant in lung adenocarcinoma confers sensitivity to alectinib. Lung Cancer. 2020;145:211\u20132.","journal-title":"Lung Cancer"},{"key":"2952_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41419-022-04561-x","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wu D-M, Luo P-W, Liu T, Han R, Deng S-H, et al. CircNEIL3 mediates pyroptosis to influence lung adenocarcinoma radiotherapy by upregulating PIF1 through miR-1184 inhibition. Cell Death Dis. 2022;13:167.","journal-title":"Cell Death Dis"},{"key":"2952_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41419-019-1591-4","volume":"10","author":"D-M Wu","year":"2019","unstructured":"Wu D-M, Zhang T, Liu Y-B, Deng S-H, Han R, Liu T, et al. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K\/AKT signaling. Cell Death Dis. 2019;10:349.","journal-title":"Cell Death Dis"},{"key":"2952_CR38","doi-asserted-by":"publisher","first-page":"e0177871","DOI":"10.1371\/journal.pone.0177871","volume":"12","author":"DO Okumu","year":"2017","unstructured":"Okumu DO, East MP, Levine M, Herring LE, Zhang R, Gilbert TSK, et al. BIRC6 mediates imatinib resistance independently of mcl-1. PLoS ONE. 2017;12:e0177871.","journal-title":"PLoS ONE"},{"key":"2952_CR39","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.2147\/DDDT.S144415","volume":"11","author":"J Zhang","year":"2017","unstructured":"Zhang J, Ming C, Zhang W, Nwabueze Okechukwu P, Morak-Mlodawska B, Pluta K, et al. 10H-3,6-Diazaphenothiazine induces G2\/M phase cell cycle arrest and caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through the regulation of NF-\u03baB and (BIRC6-XIAP) complexes. Drug Des Dev Ther. 2017;11:3045\u201363.","journal-title":"Drug Des Dev Ther"},{"issue":"9","key":"2952_CR40","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-23-2812","volume":"84","author":"ME Gedik","year":"2024","unstructured":"Gedik ME, Saatci O, Oberholtzer N, Uner M, Akbulut Caliskan O, Cetin M, et al. Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer. Cancer Res. 2024;84(9):1475\u201390.","journal-title":"Cancer Res"},{"key":"2952_CR41","doi-asserted-by":"publisher","first-page":"1382842","DOI":"10.3389\/fimmu.2024.1382842","volume":"15","author":"M Sang","year":"2024","unstructured":"Sang M, Ge J, Ge J, Tang G, Wang Q, Wu J, et al. Immune regulatory genes impact the hot\/cold tumor microenvironment, affecting cancer treatment and patient outcomes. Front Immunol. 2024;15:1382842.","journal-title":"Front Immunol"},{"key":"2952_CR42","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41592-025-02659-6","volume":"22","author":"A Banari","year":"2025","unstructured":"Banari A, Samanta AK, Munke A, Laugks T, Bajt S, Gr\u00fcnewald K, et al. Advancing time-resolved structural biology: latest strategies in cryo-EM and X-ray crystallography. Nat Methods. 2025;22:1420\u201335.","journal-title":"Nat Methods"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02952-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02952-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02952-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:37:07Z","timestamp":1784039827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02952-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2952"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02952-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Chengdu Medical College (approval number CMC-IACUC-2021024). All animal experiments were performed in strict accordance with the Regulations for the Care and Use of Laboratory Animals and Guideline for Ethical Review of Animal (China, GB\/T 35892\u2009\u2212\u20092018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}